REPL · Replimune Group Inc. Common Stock
View on chartInsiders & Stakes
| Omega Fund IV, L.P. Director | ▼ Sell | Open Market | 4,673,380 Shares held | 3/16/2022 | View profile |
| Coffin Robert President & Chief R&D Officer | ▼ Sell | Open Market | 1,821,872 Shares held | 5/16/2024 | View profile |
| Astley-Sparke Philip Chief Executive Officer | ▼ Sell | Gift | 1,362,414 Shares held | 8/20/2026 | View profile |
| Love Colin Chief Operating Officer | ▼ Sell | Open Market | 777,345 Shares held | 5/16/2024 | View profile |
| Sushil Patel Director | ▼ Sell | Open Market | 708,151 Shares held | 8/10/2026 | View profile |
| Pamela Esposito | ▼ Sell | Open Market | 263,436 Shares held | 9/12/2023 | View profile |
| Xynos Konstantinos Chief Medical Officer | ▼ Sell | Open Market | 224,215 Shares held | 8/10/2026 | View profile |
| Hill Emily Luisa Chief Financial Officer | ▼ Sell | Open Market | 215,852 Shares held | 8/17/2026 | View profile |
| Sarchi Christopher Chief Commercial Officer | ▼ Sell | Open Market | 180,962 Shares held | 6/1/2026 | View profile |
| Lewis Tanya Chief Dev.Op Off | ▼ Sell | Open Market | 135,293 Shares held | 6/13/2023 | View profile |
| Franchi Jean M. Chief Financial Officer | ▼ Sell | Open Market | 128,748 Shares held | 5/16/2023 | View profile |
| Schwendenman Andrew Chief Accounting Officer | ▼ Sell | Open Market | 99,425 Shares held | 8/10/2026 | View profile |
| Dhingra Kapil Director | ▼ Sell | Open Market | 0 Shares held | 12/9/2025 | View profile |
Transaction History
| Astley-Sparke Philip | ▼ Sell | Gift | 50,000 | $0 | 8/20/2026 |
| Hill Emily Luisa | ▼ Sell | Open Market | 9,256 | $132K | 8/17/2026 |
| Sushil Patel | ▼ Sell | Open Market | 39,341 | $510K | 8/10/2026 |
| Hill Emily Luisa | ▼ Sell | Open Market | 11,448 | $148K | 8/10/2026 |
| Xynos Konstantinos | ▼ Sell | Open Market | 11,447 | $148K | 8/10/2026 |
| Schwendenman Andrew | ▼ Sell | Open Market | 7,632 | $99K | 8/10/2026 |
| Sarchi Christopher | ▼ Sell | Open Market | 12,000 | $111K | 6/1/2026 |
| Xynos Konstantinos | ▼ Sell | Open Market | 14,023 | $71K | 5/18/2026 |
| Schwendenman Andrew | ▼ Sell | Open Market | 7,894 | $40K | 5/18/2026 |
| Sarchi Christopher | ▼ Sell | Open Market | 8,626 | $44K | 5/18/2026 |
| Astley-Sparke Philip | ▼ Sell | Open Market | 17,657 | $90K | 5/18/2026 |
| Sushil Patel | ▼ Sell | Open Market | 37,324 | $190K | 5/18/2026 |
| Hill Emily Luisa | ▼ Sell | Open Market | 7,812 | $40K | 5/18/2026 |
| Sarchi Christopher | ▼ Sell | Open Market | 6,500 | $52K | 4/2/2026 |
| Xynos Konstantinos | ▲ Buy | Grant | 50,000 | $0 | 4/1/2026 |
| Schwendenman Andrew | ▲ Buy | Grant | 36,667 | $0 | 4/1/2026 |
| Sushil Patel | ▲ Buy | Grant | 251,240 | $0 | 4/1/2026 |
| Hill Emily Luisa | ▲ Buy | Grant | 50,000 | $0 | 4/1/2026 |
| Sarchi Christopher | ▲ Buy | Grant | 50,000 | $0 | 4/1/2026 |
| Astley-Sparke Philip | ▲ Buy | Grant | 50,000 | $0 | 4/1/2026 |
| Astley-Sparke Philip | ▼ Sell | Gift | 25,000 | $0 | 2/18/2026 |
| Sushil Patel | ▲ Buy | Grant | 200,000 | $0 | 12/19/2025 |
| Xynos Konstantinos | ▲ Buy | Grant | 60,000 | $0 | 12/19/2025 |
| Hill Emily Luisa | ▲ Buy | Grant | 60,000 | $0 | 12/19/2025 |
| Sarchi Christopher | ▲ Buy | Grant | 35,000 | $0 | 12/19/2025 |
| Schwendenman Andrew | ▲ Buy | Grant | 10,000 | $0 | 12/19/2025 |
| Dhingra Kapil | ▲ Buy | Option Exercise | 3,169 | $6K | 12/9/2025 |
| Dhingra Kapil | ▼ Sell | Open Market | 3,169 | $33K | 12/9/2025 |
| Sushil Patel | ▼ Sell | Open Market | 10,000 | $111K | 12/2/2025 |
| Sarchi Christopher | ▼ Sell | Open Market | 5,208 | $47K | 11/17/2025 |
| Xynos Konstantinos | ▼ Sell | Open Market | 7,248 | $66K | 11/17/2025 |
| Hill Emily Luisa | ▼ Sell | Open Market | 9,154 | $49K | 8/15/2025 |
| Astley-Sparke Philip | ▼ Sell | Open Market | 32,279 | $260K | 5/20/2025 |
| Xynos Konstantinos | ▼ Sell | Open Market | 7,952 | $64K | 5/20/2025 |
| Sushil Patel | ▼ Sell | Open Market | 25,105 | $202K | 5/20/2025 |
| Sarchi Christopher | ▼ Sell | Open Market | 3,749 | $30K | 5/20/2025 |
| Hill Emily Luisa | ▼ Sell | Open Market | 2,535 | $20K | 5/20/2025 |
| Schwendenman Andrew | ▼ Sell | Open Market | 3,287 | $26K | 5/20/2025 |
| Sushil Patel | ▲ Buy | Grant | 166,667 | $0 | 4/1/2025 |
| Xynos Konstantinos | ▲ Buy | Grant | 45,000 | $0 | 4/1/2025 |
| Hill Emily Luisa | ▲ Buy | Grant | 45,000 | $0 | 4/1/2025 |
| Sarchi Christopher | ▲ Buy | Grant | 45,000 | $0 | 4/1/2025 |
| Schwendenman Andrew | ▲ Buy | Grant | 33,333 | $0 | 4/1/2025 |
| Sushil Patel | ▼ Sell | Open Market | 10,000 | $124K | 12/16/2024 |
| Xynos Konstantinos | ▼ Sell | Open Market | 7,246 | $78K | 11/18/2024 |
| Sarchi Christopher | ▼ Sell | Open Market | 5,207 | $56K | 11/18/2024 |
| Astley-Sparke Philip | ▼ Sell | Gift | 50,000 | $0 | 8/30/2024 |
| Hill Emily Luisa | ▼ Sell | Open Market | 8,938 | $91K | 8/16/2024 |
| Xynos Konstantinos | ▼ Sell | Open Market | 15,881 | $119K | 6/7/2024 |
| Sarchi Christopher | ▼ Sell | Open Market | 2,218 | $14K | 5/16/2024 |
| Schwendenman Andrew | ▼ Sell | Open Market | 2,298 | $15K | 5/16/2024 |
| Love Colin | ▼ Sell | Open Market | 17,615 | $114K | 5/16/2024 |
| Astley-Sparke Philip | ▼ Sell | Open Market | 37,928 | $245K | 5/16/2024 |
| Coffin Robert | ▼ Sell | Open Market | 11,464 | $74K | 5/16/2024 |
| Sushil Patel | ▼ Sell | Open Market | 20,194 | $131K | 5/16/2024 |
| Xynos Konstantinos | ▼ Sell | Open Market | 6,367 | $41K | 5/16/2024 |
| Sushil Patel | ▲ Buy | Grant | 83,335 | $0 | 4/1/2024 |
| Xynos Konstantinos | ▲ Buy | Grant | 26,665 | $0 | 4/1/2024 |
| Hill Emily Luisa | ▲ Buy | Grant | 26,665 | $0 | 4/1/2024 |
| Sarchi Christopher | ▲ Buy | Grant | 22,225 | $0 | 4/1/2024 |
| Schwendenman Andrew | ▲ Buy | Grant | 17,775 | $0 | 4/1/2024 |
| Xynos Konstantinos | ▼ Sell | Open Market | 7,313 | $80K | 11/16/2023 |
| Sarchi Christopher | ▼ Sell | Open Market | 5,255 | $57K | 11/16/2023 |
| Hill Emily Luisa | ▲ Buy | Grant | 83,330 | $0 | 9/18/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 300 | $990 | 9/12/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 300 | $6K | 9/12/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 5,358 | $18K | 9/11/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 5,358 | $107K | 9/11/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 13,600 | $45K | 8/22/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 5,000 | $78K | 8/22/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 18,600 | $372K | 8/22/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 1,400 | $5K | 8/11/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 1,400 | $28K | 8/11/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 5,000 | $78K | 7/10/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 17,923 | $388K | 7/10/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 2,077 | $44K | 7/10/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 15,000 | $50K | 7/10/2023 |
| Lewis Tanya | ▼ Sell | Open Market | 12,043 | $290K | 6/13/2023 |
| Lewis Tanya | ▼ Sell | Open Market | 817 | $19K | 6/13/2023 |
| Sushil Patel | ▼ Sell | Open Market | 5,145 | $124K | 6/13/2023 |
| Sushil Patel | ▼ Sell | Open Market | 553 | $13K | 6/13/2023 |
| Sushil Patel | ▼ Sell | Open Market | 15,575 | $281K | 5/16/2023 |
| Coffin Robert | ▼ Sell | Open Market | 7,861 | $142K | 5/16/2023 |
| Lewis Tanya | ▼ Sell | Open Market | 12,207 | $220K | 5/16/2023 |
| Love Colin | ▼ Sell | Open Market | 10,775 | $194K | 5/16/2023 |
| Franchi Jean M. | ▼ Sell | Open Market | 11,351 | $205K | 5/16/2023 |
| Xynos Konstantinos | ▼ Sell | Open Market | 771 | $14K | 5/16/2023 |
| Pamela Esposito | ▼ Sell | Open Market | 5,966 | $108K | 5/16/2023 |
| Astley-Sparke Philip | ▼ Sell | Open Market | 17,902 | $323K | 5/16/2023 |
| Xynos Konstantinos | ▲ Buy | Grant | 50,000 | $0 | 4/1/2023 |
| Franchi Jean M. | ▲ Buy | Grant | 45,000 | $0 | 4/1/2023 |
| Love Colin | ▲ Buy | Grant | 40,000 | $0 | 4/1/2023 |
| Lewis Tanya | ▲ Buy | Grant | 40,000 | $0 | 4/1/2023 |
| Sushil Patel | ▲ Buy | Grant | 40,000 | $0 | 4/1/2023 |
| Coffin Robert | ▲ Buy | Grant | 45,000 | $0 | 4/1/2023 |
| Astley-Sparke Philip | ▲ Buy | Grant | 142,100 | $0 | 4/1/2023 |
| Pamela Esposito | ▲ Buy | Grant | 40,000 | $0 | 4/1/2023 |
| Pamela Esposito | ▲ Buy | Option Exercise | 15,000 | $15K | 12/9/2022 |
| Pamela Esposito | ▼ Sell | Open Market | 15,000 | $375K | 12/9/2022 |
| Xynos Konstantinos | ▲ Buy | Grant | 17,500 | $0 | 12/1/2022 |
| Love Colin | ▼ Sell | Open Market | 6,324 | $92K | 5/16/2022 |
| Pamela Esposito | ▼ Sell | Open Market | 3,507 | $51K | 5/16/2022 |
| Franchi Jean M. | ▼ Sell | Open Market | 3,436 | $50K | 5/16/2022 |
| Lewis Tanya | ▼ Sell | Open Market | 5,473 | $80K | 5/16/2022 |
| Sushil Patel | ▼ Sell | Open Market | 10,687 | $156K | 5/16/2022 |
| Coffin Robert | ▼ Sell | Open Market | 5,737 | $84K | 5/16/2022 |
| Astley-Sparke Philip | ▼ Sell | Open Market | 9,632 | $141K | 5/16/2022 |
| Franchi Jean M. | ▲ Buy | Grant | 52,500 | $0 | 4/1/2022 |
| Sushil Patel | ▲ Buy | Grant | 52,500 | $0 | 4/1/2022 |
| Lewis Tanya | ▲ Buy | Grant | 52,500 | $0 | 4/1/2022 |
| Pamela Esposito | ▲ Buy | Grant | 22,750 | $0 | 4/1/2022 |
| Astley-Sparke Philip | ▲ Buy | Grant | 70,000 | $0 | 4/1/2022 |
| Coffin Robert | ▲ Buy | Grant | 26,250 | $0 | 4/1/2022 |
| Love Colin | ▲ Buy | Grant | 26,250 | $0 | 4/1/2022 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 6,238 | $96K | 3/16/2022 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 38,762 | $603K | 3/16/2022 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 45,000 | $704K | 3/15/2022 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 16,500 | $254K | 3/14/2022 |
| Omega Fund IV, L.P. | ▲ Buy | Option Exercise | 16,500 | $161K | 3/14/2022 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 10,162 | $353K | 11/22/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 34,845 | $1.2M | 11/19/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 417 | $15K | 11/19/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 2,441 | $82K | 11/18/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 2,441 | $82K | 11/18/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 153 | $5K | 11/16/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 153 | $5K | 11/16/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 782 | $26K | 11/15/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 23,235 | $782K | 11/12/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 18,279 | $614K | 11/11/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 11 | $369 | 11/10/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 7,537 | $254K | 11/9/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 3,817 | $128K | 11/8/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 5,790 | $194K | 11/5/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 25,225 | $847K | 11/4/2021 |
| Love Colin | ▼ Sell | Open Market | 12,711 | $376K | 10/18/2021 |
| Love Colin | ▼ Sell | Open Market | 2,200 | $69K | 10/15/2021 |
| Love Colin | ▼ Sell | Open Market | 15,089 | $457K | 10/15/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 12,171 | $409K | 9/23/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 78,998 | $2.6M | 9/17/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 15,465 | $521K | 9/17/2021 |
| Omega Fund IV, L.P. | ▼ Sell | Open Market | 5,537 | $180K | 9/16/2021 |
| Love Colin | ▼ Sell | Open Market | 30,000 | $937K | 9/15/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Replimune Launches TUDRIQEV Amidst Mixed Analyst Views
Replimune Group has launched TUDRIQEV, marking a key step in its commercial strategy. Analysts are currently assessing the product's potential, with some suggesting a wait-and-see approach until market performance becomes clearer. The stock is trading near significant support levels, reflecting cautious sentiment as investors evaluate the new launch.
Replimune Launches TUDRIQEV Amidst Mixed Analyst Views. Replimune Group has launched TUDRIQEV, marking a key step in its commercial strategy. Analysts are currently assessing the product's potential, with some suggesting a wait-and-see approach until market performance becomes clearer. The stock is trading near significant support levels, reflecting cautious sentiment as investors evaluate the new launch.